Facebook is under wider scrutiny for how it handles user data. The FBI, Securities and Exchange Commission, and Federal Trade Commission have reportedly joined the Justice Department's investigation into the relationship between Facebook and data firm Cambridge Analytica. The expanded probe, first reported by the [Washington Post](https://www.washingtonpost.com/technology/2018/07/02/federal-investigators-broaden-focus-facebooks-role-sharing-data-with-cambridge-analytica-examining-statements-tech-giant/?noredirect=on&utm_term=.4626644756e0), centers on why it took so long for the social media company to disclose the fact that Cambridge had gained access to information on tens of millions of users. Facebook has said it learned back in 2015 that Cambridge was using data gleaned from its platform to create voter profiles of users, but it only made that revelation public this past March. And while the company said it changed its data policies years ago to prevent third parties from accessing private information, just last week it said as many as 61 app developers were able to get that information even after those changes were implemented. Shares of Facebook, which have more than recovered from the initial Cambridge scandal and hit an all-time high last month, were down on the news.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More